Tocqueville Asset Management L.P. Acquires Shares of 20,952 The Cooper Companies, Inc. $COO

Key Points

• Tocqueville Asset Management initiated a 20,952-share stake in Cooper Companies worth approximately $1.5 million. Institutional investors collectively own 24.39% of the company.
• Cooper Companies beat quarterly expectations, reporting $1.21 in EPS and $1.08 billion in revenue, with revenue up 7.9% year over year. Management maintained fiscal 2026 EPS guidance of $4.58–$4.66.
• Analyst sentiment is mixed, with an average rating of Hold and an average price target of $81.64 versus the stock’s reported price of $76.16. Shares trade at a relatively high P/E ratio of about 64.5.

Tocqueville Asset Management L.P. bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 20,952 shares of the medical device company's stock, valued at approximately $1,502,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Cooper Companies by 48.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company's stock valued at $1,890,000 after acquiring an additional 7,363 shares during the last quarter. First Trust Advisors LP raised its holdings in Cooper Companies by 115.8% during the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company's stock worth $9,702,000 after purchasing an additional 73,165 shares during the last quarter. Cresset Asset Management LLC acquired a new position in Cooper Companies during the 2nd quarter valued at about $291,000. Cerity Partners LLC lifted its position in Cooper Companies by 4.4% during the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company's stock valued at $1,272,000 after purchasing an additional 757 shares during the period. Finally, Daiwa Securities Group Inc. boosted its stake in shares of Cooper Companies by 2.8% in the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company's stock valued at $2,551,000 after purchasing an additional 973 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

Cooper Companies stock opened at $76.16 on Friday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $14.85 billion, a P/E ratio of 64.54, a PEG ratio of 2.01 and a beta of 0.83. The business has a 50-day moving average of $71.76 and a 200-day moving average of $71.12. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts' consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same period last year, the company posted $0.96 EPS. Cooper Companies's revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Trending Headlines about Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: The company’s latest reported quarter showed solid operating performance: adjusted earnings of $1.21 per share exceeded consensus by $0.11, revenue reached $1.08 billion versus expectations of $1.05 billion, and sales increased 7.9% year over year. COO also maintained fiscal 2026 EPS guidance of $4.58–$4.66.
• Neutral Sentiment: Recent headlines mentioning “Cooper,” “COO,” or cooperation—including Bass Oil’s Cooper Basin update, Wendy’s discussion of a chief operating officer role, and Trainline’s regulatory cooperation—do not concern The Cooper Companies and are not relevant catalysts for COO.
• Negative Sentiment: With no fresh corporate catalyst in the provided articles, the modest weakness may reflect normal trading, profit-taking, or valuation concerns. The stock trades at a relatively high price-to-earnings multiple of about 64.5, leaving shares sensitive to changes in investor expectations even after the recent earnings beat.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on COO shares. Mizuho set a $85.00 price target on shares of Cooper Companies and gave the stock an "outperform" rating in a research report on Thursday, June 4th. The Goldman Sachs Group set a $61.00 price objective on shares of Cooper Companies in a report on Wednesday, May 27th. Needham & Company LLC reduced their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a "buy" rating on the stock in a research note on Friday, June 5th. Piper Sandler set a $86.00 target price on shares of Cooper Companies and gave the stock an "overweight" rating in a report on Monday, June 1st. Finally, Wells Fargo & Company reiterated a "sell" rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $81.64.

Cooper Companies Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source